Teva to sell generic Zocor; Dr. Reddy's to sell generic Proscar, Zocor

By Elaine Rigoli

Tampa, Fla., June 23 - Teva Pharmaceutical Industries Ltd. has received final approval from the Food and Drug Administration to market generic versions of Merck's Zocor (Simvastatin) tablets 5 mg, 10 mg, 20 mg and 40 mg.

The company said it has started shipment of the AB-rated Simvastatin tablets, indicated for the treatment of high cholesterol.

Further, Dr. Reddy's Laboratories has received approval to market Zocor 5 mg, 10 mg, 20 mg, 40 mg and 80 mg, as well as Proscar tablets 5 mg (finasteride).

The specific financial terms and conditions of the agreement have not been disclosed.

Teva, based in Jerusalem, Israel, is a generic pharmaceutical company.

Dr. Reddy's Laboratories is a global pharmaceutical company based in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.